Art
J-GLOBAL ID:201902279192911638   Reference number:19A0768072

Immunohistochemistry for Anti-diabetes Drug, Alogliptin Using a Newly Prepared Monoclonal Antibody: Its Precise Localization in Rat Small Intestine

新たに作製したモノクローナル抗体を用いる抗糖尿病薬アログリプチンの免疫組織化学:ラット小腸における正確な局在性
Author (4):
Material:
Volume: 52  Issue:Page: 27-34(J-STAGE)  Publication year: 2019 
JST Material Number: U0129A  ISSN: 1347-5800  Document type: Article
Article type: 原著論文  Country of issue: Japan (JPN)  Language: ENGLISH (EN)
Thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
,...
Semi thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.

   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=19A0768072&from=J-GLOBAL&jstjournalNo=U0129A") }}
JST classification (2):
JST classification
Category name(code) classified by JST.
Basic research of drugs acting on carbohydrate metabolism  ,  Intestines 
Substance index (1):
Substance index
Chemical Substance indexed to the Article.
Reference (35):
  • 1 Bai, J. P. (1994) Distribution of brush-border membrane peptidases along the rat intestine. Pharm. Res. 11; 897-900.
  • 2 Christopher, R., Convingtone, P., Davenport, M., Fleck, P., Mekki, Q. A., Wann, E. R. and Karim, A. (2008) Pharmaco­kinetics, pharmacodynamics, and tolerability of single increasing does of the dipeptidyl peptidase-4 inhibitor alogliptin in healthy male subjects. Clin. Ther. 30; 513-527.
  • 3 Clancy, B. and Cauller, L. J. (1998) Reduction of background autofluorescence in brain sections following immersion in sodium borohydride. J. Neurosci. Methods 83; 97-102.
  • 4 Drucker, D. J. and Nauck, N. A. (2006) The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet 368; 1696-1705.
  • 5 Egan, A. G., Blind, E., Dunder, K., de Graeff, P. A., Hummer, B. T., Bourcier, T. and Rosebraugh, C. (2014) Pancreatic safety of incretin-based drugs-FDA and EMA assessment. N. Engl. J. Med. 370; 794-797.
more...

Return to Previous Page